145 related articles for article (PubMed ID: 2414002)
1. Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
Cancer Res; 1985 Nov; 45(11 Pt 2):5904-9. PubMed ID: 2414002
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
J Biol Response Mod; 1985 Oct; 4(5):531-7. PubMed ID: 2416884
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
[No Abstract] [Full Text] [Related]
5. Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
Bever CT; Salazar AM; Neely E; Ferraraccio BE; Rose JW; McFarland HF; Levy HB; McFarlin DE
Neurology; 1986 Apr; 36(4):494-8. PubMed ID: 3960323
[TBL] [Abstract][Full Text] [Related]
6. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
Bever CT; McFarland HF; Levy HB; McFarlin DE
Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
[TBL] [Abstract][Full Text] [Related]
7. An Eastern Cooperative Oncology Group phase I-II pilot study of polyriboinosinic-polyribocytidylic acid poly-L-lysine complex in patients with metastatic malignant melanoma.
Hawkins MJ; Levin M; Borden EC
J Biol Response Mod; 1985 Dec; 4(6):664-8. PubMed ID: 2418164
[TBL] [Abstract][Full Text] [Related]
8. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
Levine AS; Sivulich M; Wiernik PH; Levy HB
Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
[No Abstract] [Full Text] [Related]
9. A phase I evaluation of poly(I,C)-LC in cancer patients.
Stevenson HC; Abrams PG; Schoenberger CS; Smalley RB; Herberman RB; Foon KA
J Biol Response Mod; 1985 Dec; 4(6):650-5. PubMed ID: 2418163
[TBL] [Abstract][Full Text] [Related]
10. A comparison of interferon responses to poly ICLC in males and females.
Bever CT; McFarlin DE; Levy HB
J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
Kende M
J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
[TBL] [Abstract][Full Text] [Related]
12. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
McFarlin DE; Bever CT; Salazar AM; Levy HB
J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
[TBL] [Abstract][Full Text] [Related]
13. Poly(I,C)-LC as an interferon inducer in refractory multiple myeloma.
Durie BG; Levy HB; Voakes J; Jett JR; Levine AS
J Biol Response Mod; 1985 Oct; 4(5):518-24. PubMed ID: 3935757
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II trials of poly IC stabilized with poly-L-lysine.
Levine AS; Levy HB
Cancer Treat Rep; 1978 Nov; 62(11):1907-12. PubMed ID: 728910
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).
Leventhal BG; Kashima H; Levine AS; Levy HB
J Pediatr; 1981 Oct; 99(4):614-6. PubMed ID: 7277106
[No Abstract] [Full Text] [Related]
16. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).
Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1986 Jul; 24(3):359-61. PubMed ID: 3721308
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of metastatic renal cell carcinoma with polyinosinic-polycytidylic acid.
Droller MJ
J Urol; 1987 Feb; 137(2):202-6. PubMed ID: 3806804
[TBL] [Abstract][Full Text] [Related]
19. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]